Department of Gastroenterological Surgery, Division of Inflammatory Bowel Disease Surgery, Hyogo Medical University, Nishinomiya, Japan.
BMC Surg. 2023 Aug 28;23(1):256. doi: 10.1186/s12893-023-02160-x.
The aim of this study was to compare the clinical characteristics of ulcerative colitis (UC) patients who underwent surgery for cancer/dysplasia with those who underwent surgery for refractory disease and to discuss the preoperative preparation for successful hand-sewn IPAA.
Patients who underwent surgery for UC between January 2014 and December 2021 at Hyogo Medical University were included in the study. A total of 443 UC surgical cases were included in the study, which comprised 188 cancer/dysplasia patients and 255 refractory patients. Clinical records were compared retrospectively.
The proportion of surgical UC cases with cancer/dysplasia has been on the rise, accounting for approximately 40% in recent years. The duration of disease (months) was 186 (2-590) in the cancer/dysplasia group and 48 (1-580) in the refractory group (p = 0.02). UC severity (mild/moderate/severe) was 119/69/0 in the cancer/dysplasia group and 18/157/80 in the refractory group (p < 0.01). The four nutrition factors of weight (55.2 (32.7-99.6) kg: 49.9 (20.3-85.2) kg), body mass index (21.0 (13.9-32.5) kg/m2: 18.3 (11.4-34.1)kg/m2), serum albumin level (4.3 (2.7-5.0)g/dl: 3.4 (1.4-5.2)g/dl) and prognostic nutrition index (49.2 (33.2-61.2): 40.9 (17.4-61.1)) were significantly higher in the cancer/dysplasia group (p < 0.01). The degree of obesity was also significantly higher in the cancer/dysplasia group (p < 0.01).
UC patients with cancer/dysplasia were more likely than refractory patients to have mild inflammation; they also had a longer duration of UC disease and better nutritional status.
本研究旨在比较溃疡性结肠炎(UC)患者因癌症/异型增生而行手术与因难治性疾病而行手术的临床特征,并探讨成功实施手缝回肠贮袋肛管吻合术(IPAA)的术前准备。
纳入 2014 年 1 月至 2021 年 12 月期间在兵库医科大学行手术治疗的 UC 患者。共纳入 443 例 UC 手术病例,其中 188 例为癌症/异型增生患者,255 例为难治性患者。回顾性比较临床记录。
具有癌症/异型增生的手术 UC 病例比例呈上升趋势,近年来约占 40%。癌症/异型增生组的疾病持续时间(月)为 186(2-590),难治性组为 48(1-580)(p=0.02)。UC 严重程度(轻度/中度/重度)在癌症/异型增生组分别为 119/69/0,在难治性组分别为 18/157/80(p<0.01)。体重(55.2(32.7-99.6)kg:49.9(20.3-85.2)kg)、体重指数(21.0(13.9-32.5)kg/m2:18.3(11.4-34.1)kg/m2)、血清白蛋白水平(4.3(2.7-5.0)g/dl:3.4(1.4-5.2)g/dl)和预后营养指数(49.2(33.2-61.2):40.9(17.4-61.1))这 4 项营养因素在癌症/异型增生组显著更高(p<0.01)。肥胖程度在癌症/异型增生组也显著更高(p<0.01)。
与难治性患者相比,具有癌症/异型增生的 UC 患者炎症程度更轻,UC 疾病持续时间更长,营养状况更好。